The Latin America, Middle East and Africa Scar Treatment Market would witness market growth of 13.7% CAGR during the forecast period (2022-2028).
No matter what kind of problem they are attempting to solve, the vast majority of individuals will choose solutions that allow them to circumvent the need for invasive medical procedures. When someone has acne scar laser treatment, they may anticipate a non-invasive procedure that does not entail any invasive surgery. This is because the laser treatment does not penetrate the skin. Laser technology is used to perform the skin resurfacing procedure, which is one of the reasons why people choose this option rather than others.
When dealing with skin disorders such as acne scars, it is normal for individuals to search for a therapy that provides a balance of safety and convenience in addition to observable outcomes. A great number of individuals have reaped these advantages from this therapy, and they have expressed their relief at being able to achieve results while enduring a treatment that is not only risk-free but also quite convenient.
Anyone who has suffered from noticeable skin disorders and issues, such as acne scars, is aware of the significant toll that it can have on one's sense of self-worth and confidence levels. Acne scar laser therapy is considered successful when the patient may confidently walk out of the clinic.
Burns to the skin are widespread in Saudi Arabia, with females being more likely to suffer from them. The vast majority of burns on the skin happen at home, and the most common culprit is hot water, which mostly affects the hands. The vast majority of burns are treated with lotions applied directly to the affected area, but more severe cases may need skin grafting. The Saudi community exhibits a degree of acceptability that is comparable to that of other populations about the results of treatment for skin burns.
The Brazil market dominated the LAMEA Scar Treatment Market by Country in 2021; thereby, achieving a market value of $784.2 million by 2028. The Argentina market is showcasing a CAGR of 14.3% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 13.4% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals, Clinics, and Retail Pharmacies/ E-commerce. Based on Product, the market is segmented into Topical Products (Creams, Gels, Silicon Sheets, and Others), Laser Products, Injectables, and Others. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Cynosure, LLC, Molnlycke Health Care AB (Investor AB), Suneva Medical, Inc., Perrigo Company PLC, Sientra, Inc., Bausch Health Companies, Inc. and Alma Lasers (Sisram Medical Ltd.)
No matter what kind of problem they are attempting to solve, the vast majority of individuals will choose solutions that allow them to circumvent the need for invasive medical procedures. When someone has acne scar laser treatment, they may anticipate a non-invasive procedure that does not entail any invasive surgery. This is because the laser treatment does not penetrate the skin. Laser technology is used to perform the skin resurfacing procedure, which is one of the reasons why people choose this option rather than others.
When dealing with skin disorders such as acne scars, it is normal for individuals to search for a therapy that provides a balance of safety and convenience in addition to observable outcomes. A great number of individuals have reaped these advantages from this therapy, and they have expressed their relief at being able to achieve results while enduring a treatment that is not only risk-free but also quite convenient.
Anyone who has suffered from noticeable skin disorders and issues, such as acne scars, is aware of the significant toll that it can have on one's sense of self-worth and confidence levels. Acne scar laser therapy is considered successful when the patient may confidently walk out of the clinic.
Burns to the skin are widespread in Saudi Arabia, with females being more likely to suffer from them. The vast majority of burns on the skin happen at home, and the most common culprit is hot water, which mostly affects the hands. The vast majority of burns are treated with lotions applied directly to the affected area, but more severe cases may need skin grafting. The Saudi community exhibits a degree of acceptability that is comparable to that of other populations about the results of treatment for skin burns.
The Brazil market dominated the LAMEA Scar Treatment Market by Country in 2021; thereby, achieving a market value of $784.2 million by 2028. The Argentina market is showcasing a CAGR of 14.3% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 13.4% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals, Clinics, and Retail Pharmacies/ E-commerce. Based on Product, the market is segmented into Topical Products (Creams, Gels, Silicon Sheets, and Others), Laser Products, Injectables, and Others. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Cynosure, LLC, Molnlycke Health Care AB (Investor AB), Suneva Medical, Inc., Perrigo Company PLC, Sientra, Inc., Bausch Health Companies, Inc. and Alma Lasers (Sisram Medical Ltd.)
Scope of the Study
Market Segments Covered in the Report:
By End-use
- Hospitals
- Clinics
- Retail Pharmacies/ E-commerce
By Product
- Topical Products
- Creams
- Gels
- Silicon Sheets
- Others
- Laser Products
- Injectables
- Others
By Scar Type
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Smith & Nephew PLC
- Lumenis Be Ltd
- Merz Pharma GmbH & Co. KGaA
- Cynosure, LLC
- Molnlycke Health Care AB (Investor AB)
- Suneva Medical, Inc
- Perrigo Company PLC
- Sientra, Inc
- Bausch Health Companies, Inc
- Alma Lasers (Sisram Medical Ltd.)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Scar Treatment Market, by End-use
1.4.2 LAMEA Scar Treatment Market, by Product
1.4.3 LAMEA Scar Treatment Market, by Scar Type
1.4.4 LAMEA Scar Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Scar Treatment Market
Chapter 4. LAMEA Scar Treatment Market by End-use
4.1 LAMEA Hospitals Market by Country
4.2 LAMEA Clinics Market by Country
4.3 LAMEA Retail Pharmacies/ E-commerce Market by Country
Chapter 5. LAMEA Scar Treatment Market by Product
5.1 LAMEA Topical Products Market by Country
5.2 LAMEA Scar Treatment Market by Topical Products Type
5.2.1 LAMEA Creams Market by Country
5.2.2 LAMEA Gels Market by Country
5.2.3 LAMEA Silicon Sheets Market by Country
5.2.4 LAMEA Others Market by Country
5.3 LAMEA Laser Products Market by Country
5.4 LAMEA Injectables Market by Country
5.5 LAMEA Others Market by Country
Chapter 6. LAMEA Scar Treatment Market by Scar Type
6.1 LAMEA Atrophic Scars Market by Country
6.2 LAMEA Hypertrophic & Keloid Scars Market by Country
6.3 LAMEA Contracture Scars Market by Country
6.4 LAMEA Stretch Marks Market by Country
Chapter 7. LAMEA Scar Treatment Market by Country
7.1 Brazil Scar Treatment Market
7.1.1 Brazil Scar Treatment Market by End-use
7.1.2 Brazil Scar Treatment Market by Product
7.1.2.1 Brazil Scar Treatment Market by Topical Products Type
7.1.3 Brazil Scar Treatment Market by Scar Type
7.2 Argentina Scar Treatment Market
7.2.1 Argentina Scar Treatment Market by End-use
7.2.2 Argentina Scar Treatment Market by Product
7.2.2.1 Argentina Scar Treatment Market by Topical Products Type
7.2.3 Argentina Scar Treatment Market by Scar Type
7.3 UAE Scar Treatment Market
7.3.1 UAE Scar Treatment Market by End-use
7.3.2 UAE Scar Treatment Market by Product
7.3.2.1 UAE Scar Treatment Market by Topical Products Type
7.3.3 UAE Scar Treatment Market by Scar Type
7.4 Saudi Arabia Scar Treatment Market
7.4.1 Saudi Arabia Scar Treatment Market by End-use
7.4.2 Saudi Arabia Scar Treatment Market by Product
7.4.2.1 Saudi Arabia Scar Treatment Market by Topical Products Type
7.4.3 Saudi Arabia Scar Treatment Market by Scar Type
7.5 South Africa Scar Treatment Market
7.5.1 South Africa Scar Treatment Market by End-use
7.5.2 South Africa Scar Treatment Market by Product
7.5.2.1 South Africa Scar Treatment Market by Topical Products Type
7.5.3 South Africa Scar Treatment Market by Scar Type
7.6 Nigeria Scar Treatment Market
7.6.1 Nigeria Scar Treatment Market by End-use
7.6.2 Nigeria Scar Treatment Market by Product
7.6.2.1 Nigeria Scar Treatment Market by Topical Products Type
7.6.3 Nigeria Scar Treatment Market by Scar Type
7.7 Rest of LAMEA Scar Treatment Market
7.7.1 Rest of LAMEA Scar Treatment Market by End-use
7.7.2 Rest of LAMEA Scar Treatment Market by Product
7.7.2.1 Rest of LAMEA Scar Treatment Market by Topical Products Type
7.7.3 Rest of LAMEA Scar Treatment Market by Scar Type
Chapter 8. Company Profiles
8.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Product Line and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.1.5.2 Acquisitions and Mergers:
8.2 Perrigo Company PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Bausch Health Companies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Sientra, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Molnlycke Health Care AB (Investor AB)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.6 Smith & Nephew PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional and Segmental Analysis
8.6.4 Research & Development Expense
8.7 Cynosure, LLC
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.7.2.2 Product Launches and Product Expansions:
8.8 Suneva Medical, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 Lumenis Be Ltd.
8.9.1 Company Overview
8.10. Merz Pharma GmbH & Co. KGaA
8.10.1 Company Overview
Companies Mentioned
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Cynosure, LLC
- Molnlycke Health Care AB (Investor AB)
- Suneva Medical, Inc.
- Perrigo Company PLC
- Sientra, Inc.
- Bausch Health Companies, Inc.
- Alma Lasers (Sisram Medical Ltd.)
Methodology
LOADING...
